|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||401.53 g·mol−1|
|3D model (JSmol)|
E-4031 is an experimental class III antiarrhythmic drug that blocks potassium channels of the hERG-type.
E-4031 is a synthetized toxin that is a methanesulfonanilide class III antiarrhythmic drug.
E-4031 acts on a specific class of voltage-gated potassium channels mainly found in the heart, the hERG channels. hERG channels (Kv11.1) mediate the IKr current, which repolarizes the myocardial cells. The hERG channel is encoded by ether-a-go-go related gene (hERG).
E-4031 blocks hERG-type potassium channels  by binding to the open channels. Its structural target within the hERG-channel is unclear, but some other methanesulfonanilide class III antiarrhythmic drugs are known to bind to the S6 domain or C-terminal of the hERG-channel.
Reducing IKr in myocardial cells prolongs the cardiac action potential and thus prolongs the QT-interval. In non-cardiac cells, blocking Ikr has a different effect: it increases the frequency of action potentials.
As E-4031 can prolong the QT-interval, it can cause lethal arrhythmias.
E-4031 is solely used for research purposes. So far, one clinical trial has been conducted to test the effect of E-4031 on prolongation of the QT-interval.